Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT

Takashi Kanbayashi, Ko Tsutsui, Keiko Tanaka, Yuki Omori, Manabu Takaki, Mayu Omokawa, Akane Mori, Hiroaki Kusanagi, Seiji Nishino, Tetsuo Shimizu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The symptoms of malignant (lethal) catatonia has been reported similar to initial symptoms of anti-NMDAR encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed in many psychiatrists. We have experienced several cases with malignant catatonia having anti-NMDAR antibody without clinical signs of encephalitis. Thereafter, we have also found anti-NMDAR antibody positive patients of young females with acute florid psychiatric symptoms without clinical signs of encephalitis. The features of these patients mirror-those of "Atypical psychosis" proposed by Mitsuda in Japan, a notion derived from "Cycloid psychosis" conceptualized by German psychiatrist, Leonhard. Both cycloid and atypical psychosis have coinciding features of acute onset, emotional disturbances, psychomotor disturbances, alternations of consciousness, high prevalence in women and oriented premorbid personality. Both malignant catatonia and atypical psychosis have been known to be effectively treated with modified electro convulsion therapy (m-ECT). Our 5 cases with anti-NMDAR antibody, m-ECT treatments were effective. Infectious encephalitis is contra indication of m-ECT, but this autoimmune encephalitis would be careful indication. Schizophrenia is a common, heterogeneous, and complex disorder with unknown etiology. There is established evidence of NMDAR hypofunction as a central component of the functional disconnectivity; this is one of the most accepted models for schizophrenia. Moreover, autoimmune mechanisms have been proposed to be involved, at least in subgroups of schizophrenia patients. Further research of anti-NMDAR antibody and encephalitis would be important clues for the investigation of schizophrenia, catatonia and atypical psychosis.

Original languageEnglish
Pages (from-to)1103-1106
Number of pages4
JournalClinical Neurology
Volume54
Issue number12
Publication statusPublished - 2014

Fingerprint

Catatonia
Encephalitis
N-Methylaspartate
Psychotic Disorders
Psychiatry
Anti-Idiotypic Antibodies
Schizophrenia
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Seizures
Affective Symptoms
Therapeutics
Consciousness
Personality
Japan
Research

Keywords

  • Anti-NMDA receptor encephalitis
  • Atypical psychosis
  • M-ECT
  • Malignant catatonia

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Kanbayashi, T., Tsutsui, K., Tanaka, K., Omori, Y., Takaki, M., Omokawa, M., ... Shimizu, T. (2014). Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT. Clinical Neurology, 54(12), 1103-1106.

Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT. / Kanbayashi, Takashi; Tsutsui, Ko; Tanaka, Keiko; Omori, Yuki; Takaki, Manabu; Omokawa, Mayu; Mori, Akane; Kusanagi, Hiroaki; Nishino, Seiji; Shimizu, Tetsuo.

In: Clinical Neurology, Vol. 54, No. 12, 2014, p. 1103-1106.

Research output: Contribution to journalArticle

Kanbayashi, T, Tsutsui, K, Tanaka, K, Omori, Y, Takaki, M, Omokawa, M, Mori, A, Kusanagi, H, Nishino, S & Shimizu, T 2014, 'Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT', Clinical Neurology, vol. 54, no. 12, pp. 1103-1106.
Kanbayashi T, Tsutsui K, Tanaka K, Omori Y, Takaki M, Omokawa M et al. Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT. Clinical Neurology. 2014;54(12):1103-1106.
Kanbayashi, Takashi ; Tsutsui, Ko ; Tanaka, Keiko ; Omori, Yuki ; Takaki, Manabu ; Omokawa, Mayu ; Mori, Akane ; Kusanagi, Hiroaki ; Nishino, Seiji ; Shimizu, Tetsuo. / Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT. In: Clinical Neurology. 2014 ; Vol. 54, No. 12. pp. 1103-1106.
@article{5f2a2c72372048caae1ae437a0913f46,
title = "Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT",
abstract = "The symptoms of malignant (lethal) catatonia has been reported similar to initial symptoms of anti-NMDAR encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed in many psychiatrists. We have experienced several cases with malignant catatonia having anti-NMDAR antibody without clinical signs of encephalitis. Thereafter, we have also found anti-NMDAR antibody positive patients of young females with acute florid psychiatric symptoms without clinical signs of encephalitis. The features of these patients mirror-those of {"}Atypical psychosis{"} proposed by Mitsuda in Japan, a notion derived from {"}Cycloid psychosis{"} conceptualized by German psychiatrist, Leonhard. Both cycloid and atypical psychosis have coinciding features of acute onset, emotional disturbances, psychomotor disturbances, alternations of consciousness, high prevalence in women and oriented premorbid personality. Both malignant catatonia and atypical psychosis have been known to be effectively treated with modified electro convulsion therapy (m-ECT). Our 5 cases with anti-NMDAR antibody, m-ECT treatments were effective. Infectious encephalitis is contra indication of m-ECT, but this autoimmune encephalitis would be careful indication. Schizophrenia is a common, heterogeneous, and complex disorder with unknown etiology. There is established evidence of NMDAR hypofunction as a central component of the functional disconnectivity; this is one of the most accepted models for schizophrenia. Moreover, autoimmune mechanisms have been proposed to be involved, at least in subgroups of schizophrenia patients. Further research of anti-NMDAR antibody and encephalitis would be important clues for the investigation of schizophrenia, catatonia and atypical psychosis.",
keywords = "Anti-NMDA receptor encephalitis, Atypical psychosis, M-ECT, Malignant catatonia",
author = "Takashi Kanbayashi and Ko Tsutsui and Keiko Tanaka and Yuki Omori and Manabu Takaki and Mayu Omokawa and Akane Mori and Hiroaki Kusanagi and Seiji Nishino and Tetsuo Shimizu",
year = "2014",
language = "English",
volume = "54",
pages = "1103--1106",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "12",

}

TY - JOUR

T1 - Anti-NMDA encephalitis in psychiatry; malignant catatonia, atypical psychosis and ECT

AU - Kanbayashi, Takashi

AU - Tsutsui, Ko

AU - Tanaka, Keiko

AU - Omori, Yuki

AU - Takaki, Manabu

AU - Omokawa, Mayu

AU - Mori, Akane

AU - Kusanagi, Hiroaki

AU - Nishino, Seiji

AU - Shimizu, Tetsuo

PY - 2014

Y1 - 2014

N2 - The symptoms of malignant (lethal) catatonia has been reported similar to initial symptoms of anti-NMDAR encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed in many psychiatrists. We have experienced several cases with malignant catatonia having anti-NMDAR antibody without clinical signs of encephalitis. Thereafter, we have also found anti-NMDAR antibody positive patients of young females with acute florid psychiatric symptoms without clinical signs of encephalitis. The features of these patients mirror-those of "Atypical psychosis" proposed by Mitsuda in Japan, a notion derived from "Cycloid psychosis" conceptualized by German psychiatrist, Leonhard. Both cycloid and atypical psychosis have coinciding features of acute onset, emotional disturbances, psychomotor disturbances, alternations of consciousness, high prevalence in women and oriented premorbid personality. Both malignant catatonia and atypical psychosis have been known to be effectively treated with modified electro convulsion therapy (m-ECT). Our 5 cases with anti-NMDAR antibody, m-ECT treatments were effective. Infectious encephalitis is contra indication of m-ECT, but this autoimmune encephalitis would be careful indication. Schizophrenia is a common, heterogeneous, and complex disorder with unknown etiology. There is established evidence of NMDAR hypofunction as a central component of the functional disconnectivity; this is one of the most accepted models for schizophrenia. Moreover, autoimmune mechanisms have been proposed to be involved, at least in subgroups of schizophrenia patients. Further research of anti-NMDAR antibody and encephalitis would be important clues for the investigation of schizophrenia, catatonia and atypical psychosis.

AB - The symptoms of malignant (lethal) catatonia has been reported similar to initial symptoms of anti-NMDAR encephalitis. Subsequently, this autoimmune limbic encephalitis has been noticed in many psychiatrists. We have experienced several cases with malignant catatonia having anti-NMDAR antibody without clinical signs of encephalitis. Thereafter, we have also found anti-NMDAR antibody positive patients of young females with acute florid psychiatric symptoms without clinical signs of encephalitis. The features of these patients mirror-those of "Atypical psychosis" proposed by Mitsuda in Japan, a notion derived from "Cycloid psychosis" conceptualized by German psychiatrist, Leonhard. Both cycloid and atypical psychosis have coinciding features of acute onset, emotional disturbances, psychomotor disturbances, alternations of consciousness, high prevalence in women and oriented premorbid personality. Both malignant catatonia and atypical psychosis have been known to be effectively treated with modified electro convulsion therapy (m-ECT). Our 5 cases with anti-NMDAR antibody, m-ECT treatments were effective. Infectious encephalitis is contra indication of m-ECT, but this autoimmune encephalitis would be careful indication. Schizophrenia is a common, heterogeneous, and complex disorder with unknown etiology. There is established evidence of NMDAR hypofunction as a central component of the functional disconnectivity; this is one of the most accepted models for schizophrenia. Moreover, autoimmune mechanisms have been proposed to be involved, at least in subgroups of schizophrenia patients. Further research of anti-NMDAR antibody and encephalitis would be important clues for the investigation of schizophrenia, catatonia and atypical psychosis.

KW - Anti-NMDA receptor encephalitis

KW - Atypical psychosis

KW - M-ECT

KW - Malignant catatonia

UR - http://www.scopus.com/inward/record.url?scp=84919781107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919781107&partnerID=8YFLogxK

M3 - Article

VL - 54

SP - 1103

EP - 1106

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 12

ER -